SCREENING FOR DIABETIC RETINOPATHY IN HONG KONG- IS INVERSE CARE LAW OPERATING?

Author(s)

Lian JX1, McGhee SM1, Chan CKW1, Wong SH1, Yap KH2, Lam LK1, Hedley AJ1, Gangwani RA1, Chu WS31University of Hong Kong, Hong Kong, Hong Kong, 2Hong Kong Polytechnic University, Hong Kong, Hong Kong, 3Hong Kong Hospital Authority, Hong Kong, Hong Kong

OBJECTIVES: The Inverse Care Law, whereby health care services are less accessible to those in greater need, has been found to operate in a variety of health systems.  Tudor Hart asserted that market forces would exaggerate the maldistribution of resources. The objective of this study is to examine whether the inverse care law operates in a screening program for diabetic retinopathy (DR) in Hong Kong (HK) with a mixed medical economy like other Asian countries. METHODS: A randomized controlled trial has been conducted.  All those with Type 1 or Type 2 diabetes from two public primary care clinics in Hong Kong were recruited and then were randomly allocated into one group paying a fee of HK$60 (US$8) for screening  and the other group with free access. The outcome measures are uptake of screening and extent of DR detected. RESULTS: After randomization, 1387 in free and 1379 in pay groups were eligible for screening. 94.9%(1316/1387) and 92.6%(1277/1379)respectively agreed to participate in the study. The final screening uptake rate were 88.5% (1165/1316)and 82.4% (1052/1277)respectively (P<0.001). Being in the pay group was associated with lower uptake of screening than in the free group (OR=0.59, 0.47-0.74) and lower prevalence of DR detected (20.3% VS 25.9%, P=0.004).  Subjects with higher socioeconomic status were more likely to take up screening but with less DR detected. CONCLUSIONS: The inverse care law appears to operate in a preventive intervention even with a relatively small co-payment. There is a strong case for making effective preventive services free of charge.

Conference/Value in Health Info

2012-09, ISPOR Asia Pacific 2012, Taipei, Taiwan

Value in Health, Vol. 15, No. 7 (November 2012)

Code

DB4

Topic

Health Policy & Regulatory

Topic Subcategory

Health Disparities & Equity

Disease

Diabetes/Endocrine/Metabolic Disorders, Sensory System Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×